Ocugen News

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Ocugen Inc OCGN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0411 -1.84% 2.1889 10:03:08
Open Price Low Price High Price Close Price Prev Close
2.21 2.13 2.23 2.23
more quote information »

Recent News

Date Time Source Heading
1/12/202112:06EDGARCurrent Report Filing (8-k)
1/12/202112:03EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
1/12/202107:52GLOBEOcugen Inc. Announces the Cancellation of Stockholder..
1/08/202116:02EDGARCurrent Report Filing (8-k)
1/08/202115:17GLOBEOcugen Inc. Regains Compliance with Nasdaq Bid Price Rule
1/08/202108:00GLOBEOcugen Inc. to Present at CTIC, HC Wainwright and Noble..
1/05/202117:24EDGARCurrent Report Filing (8-k)
1/04/202117:51EDGARStatement of Changes in Beneficial Ownership (4)
1/04/202117:47EDGARStatement of Changes in Beneficial Ownership (4)
1/04/202117:44EDGARStatement of Changes in Beneficial Ownership (4)
1/04/202117:43EDGARStatement of Changes in Beneficial Ownership (4)
1/04/202117:40EDGARStatement of Changes in Beneficial Ownership (4)
1/04/202117:38EDGARStatement of Changes in Beneficial Ownership (4)
1/04/202117:27EDGARStatement of Changes in Beneficial Ownership (4)
12/23/202019:15GLOBEOcugen Establishes Vaccine Scientific Advisory Board
12/23/202011:58TRMNIs Ocugen Stock Still Worth Buying After Its 800%-Plus..
12/23/202006:03EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
12/22/202021:07GLOBEOcugen Inc. Announces Plan to Adjourn Annual Meeting of..
12/22/202007:30GLOBEOcugen and Bharat Biotech to Co-Develop COVAXIN™, a..
12/11/202006:01EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
12/10/202017:44GLOBEOcugen Inc. Announces Plan to Postpone Annual Meeting of..
12/02/202006:02EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
12/01/202017:53GLOBELeading Independent Proxy Firms ISS and Glass Lewis..
11/27/202008:08GLOBECEO Dr. Shankar Musunuri to be Featured as a Panelist at..
11/06/202008:06EDGARCurrent Report Filing (8-k)
11/06/202008:02EDGARQuarterly Report (10-q)
11/06/202007:41EDGARCurrent Report Filing (8-k)
11/06/202007:30GLOBEOcugen Provides Business Update and Third Quarter 2020..
10/30/202017:14EDGARProxy Statement (definitive) (def 14a)
10/29/202008:45GLOBEOcugen to Present at the GCFF Virtual Conference -..
10/22/202007:30GLOBECEO Dr. Shankar Musunuri to Discuss the Importance of Gene..
10/20/202009:17EDGARCurrent Report Filing (8-k)
10/16/202007:30GLOBECantor Fitzgerald and Kristen Kluska to Host Zoom Fireside..
10/06/202008:51EDGARCurrent Report Filing (8-k)
10/06/202007:30GLOBEOcugen Engages Kemwell Biopharma for cGMP Manufacture of..
9/29/202007:35GLOBEOcugen to Participate in a Virtual Fireside Chat at the..
9/16/202007:30GLOBEOcugen to Present at the Oppenheimer Fall Healthcare Life..
9/08/202016:26GLOBEOcugen Granted 180-Day Extension by Nasdaq to Regain..
9/03/202007:30GLOBEOcugen to Present at the H.C. Wainwright 22nd Annual Global..
8/28/202007:40GLOBEOcugen to Present at the LD 500 Virtual Investor Conference
8/17/202019:56EDGARStatement of Changes in Beneficial Ownership (4)
8/17/202009:17EDGARCurrent Report Filing (8-k)
8/17/202006:26EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
8/17/202006:21EDGARCurrent Report Filing (8-k)
8/14/202007:39EDGARCurrent Report Filing (8-k)
8/14/202007:37EDGARQuarterly Report (10-q)
8/14/202007:30GLOBEOcugen Provides Business Update and Second Quarter 2020..
8/10/202008:32EDGARCurrent Report Filing (8-k)
8/10/202007:30GLOBEOcugen Receives Fourth FDA Orphan Drug Designation for the..
8/06/202013:45GLOBEOcugen to Host Conference Call on Friday, August 14 at 8:30..
See more news about this stock »
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210121 15:18:25